Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?

Lizza E.L. Hendriks*, Anita J.W.M. Brouns, Mohammad Amini, Wilma Uyterlinde, Robin Wijsman, Jan Bussink, Bonne Biesma, S. Bing Oei, Jos A. Stigt, Gerben P. Bootsma, José S.A. Belderbos, Dirk K.M. De Ruysscher, Michel M. Van den Heuvel, Anne Marie C. Dingemans

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

12 Citations (Scopus)
3 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences

Immunology and Microbiology